Sailybio
Shanghai, China | +86 21 5808 0192
Menu
Shanghai, China
+86 21 5808 0192

Do you support investigator-initiated trials in China?

publish:2026-11-04 13:38:51  author :Sailybio    views :0
Sailybio publish:2026-11-04 13:38:51  
0

Yes, through our clinical team and a network of more than 20 tier-one hospitals. Scope covers feasibility assessment, scientific protocol review, site and principal investigator mapping, budget and contracting, regulatory pathway advice for the different IIT routes, and project management, monitoring, data management and medical writing. For overseas sponsors this is often the fastest route to first-in-human data, and site costs typically run 30 to 50 percent below comparable US or Western European work. Many programs start with a single-site feasibility study before committing to a multi-center design.

share to:

Long press to recognize and share with friends

Long press to recognize and share with friends
Copyright @ 2026 SAILYBIO. All rights reserved
Powerby Feedback Follow Data